FMO3 loss or gain-of-function experiments in cholesterol fed mice demonstrated that TMAO induces ABCG5 and ABCG8 expression, and presumably increases bile cholesterol content to drive gallstone formation [117]. This evidence concerns the gene FMO3 and gallstones.